Arbutus Biopharma (ABUS) Preferred Shares Issued (2017 - 2018)
Arbutus Biopharma's (ABUS) quarterly Preferred Shares Issued came in at $66.3 million in Q1 2018, up 35.6% quarter-over-quarter from $48.9 million in Q4 2017.
Arbutus Biopharma (ABUS) Preferred Shares Issued (2017 - 2018) Analysis & Trends
Arbutus Biopharma has disclosed Preferred Shares Issued across 2 years of filings, most recently posting $66.3 million for Q1 2018.
- Preferred Shares Issued for Q1 2018 came in at $66.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was $66.3 million (up 35.6% YoY), and the FY2018 annual result was $66.3 million, up 35.6% from the prior year.
- Preferred Shares Issued came in at $66.3 million for Q1 2018 at Arbutus Biopharma, up from $48.9 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $66.3 million in Q1 2018 to a low of $48.9 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arbutus Biopharma | 882.62 Mn | 882.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 66.27 Mn |
| Mar 31, 2018 | 66.27 Mn |
| Dec 31, 2017 | 48.87 Mn |
| Dec 31, 2017 | 48.87 Mn |